116 related articles for article (PubMed ID: 37572408)
1. Acute intoxication caused by three common synthetic cannabinoids: The experience of a large, urban, tertiary care hospital.
Shopan N; Scolnik D; Hassoun E; Firsow A; Volkov I; Glatstein M
Am J Emerg Med; 2023 Nov; 73():7-10. PubMed ID: 37572408
[TBL] [Abstract][Full Text] [Related]
2. Critical Illness Secondary to Synthetic Cannabinoid Ingestion.
Kourouni I; Mourad B; Khouli H; Shapiro JM; Mathew JP
JAMA Netw Open; 2020 Jul; 3(7):e208516. PubMed ID: 32687586
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study.
Hakimian D; Benson AA; Khoury T; Massarwa M; Israel S; Salameh S; Gershinsky Y; Shapira B; Muszkat M
BMC Gastroenterol; 2021 Jul; 21(1):274. PubMed ID: 34229620
[TBL] [Abstract][Full Text] [Related]
4. Respiratory failure in confirmed synthetic cannabinoid overdose.
Manini AF; Krotulski AJ; Schimmel J; Allen L; Hurd YL; Richardson LD; Vidal K; Logan BK
Clin Toxicol (Phila); 2022 Apr; 60(4):524-526. PubMed ID: 34499005
[TBL] [Abstract][Full Text] [Related]
5. [Metabolism of New Psychoactive Substances 4F-MDMB-BUTINACA in Zebrafish].
Yue LN; Xiang P; Song FY; Shen BH; Yan H
Fa Yi Xue Za Zhi; 2021 Aug; 37(4):493-499. PubMed ID: 34726001
[TBL] [Abstract][Full Text] [Related]
6. Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.
Bäckberg M; Tworek L; Beck O; Helander A
J Med Toxicol; 2017 Mar; 13(1):52-60. PubMed ID: 27638057
[TBL] [Abstract][Full Text] [Related]
7. Synthetic Cannabinoid-Associated Multiple Organ Failure: Case Series and Literature Review.
Armstrong F; McCurdy MT; Heavner MS
Pharmacotherapy; 2019 Apr; 39(4):508-513. PubMed ID: 30811628
[TBL] [Abstract][Full Text] [Related]
8. Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015.
Abouchedid R; Hudson S; Thurtle N; Yamamoto T; Ho JH; Bailey G; Wood M; Sadones N; Stove CP; Dines A; Archer JRH; Wood DM; Dargan PI
Clin Toxicol (Phila); 2017 Jun; 55(5):338-345. PubMed ID: 28421836
[TBL] [Abstract][Full Text] [Related]
9. Molecular signaling of synthetic cannabinoids: Comparison of CB1 receptor and TRPV1 channel activation.
Andersen HK; Walsh KB
Eur J Pharmacol; 2021 Sep; 907():174301. PubMed ID: 34224700
[TBL] [Abstract][Full Text] [Related]
10. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
Besli GE; Ikiz MA; Yildirim S; Saltik S
J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids.
Gatch MB; Forster MJ
Neurotoxicology; 2019 Jan; 70():72-79. PubMed ID: 30439379
[TBL] [Abstract][Full Text] [Related]
12. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
[TBL] [Abstract][Full Text] [Related]
13. Clinical effects of reported synthetic cannabinoid exposure in patients admitted to the intensive care unit.
Tatusov M; Mazer-Amirshahi M; Abbasi A; Goyal M
Am J Emerg Med; 2019 Jun; 37(6):1060-1064. PubMed ID: 30146395
[TBL] [Abstract][Full Text] [Related]
14. Behavioral pharmacology of five novel synthetic cannabinoids.
Gatch MB; Tourigny A; Shetty RA; Forster MJ
Behav Pharmacol; 2022 Apr; 33(2&3):175-183. PubMed ID: 33595956
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
16. Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?
Tebo C; Mazer-Amirshahi M; DeGeorge L; Gelfand B; Leak C; Tolliver S; Sauter D
Am J Emerg Med; 2019 Oct; 37(10):1846-1849. PubMed ID: 30595429
[TBL] [Abstract][Full Text] [Related]
17. Emergency physicians' knowledge of cannabinoid designer drugs.
Lank PM; Pines E; Mycyk MB
West J Emerg Med; 2013 Sep; 14(5):467-70. PubMed ID: 24106544
[TBL] [Abstract][Full Text] [Related]
18. Retrospective Chart Review of Synthetic Cannabinoid Intoxication with Toxicologic Analysis.
Sud P; Gordon M; Tortora L; Stripp M; Borg D; Berman A
West J Emerg Med; 2018 May; 19(3):567-572. PubMed ID: 29760857
[TBL] [Abstract][Full Text] [Related]
19. [Identification of Synthetic Cannabinoid New Psychoactive Substances 4F-MDMB-BUTINACA and MDMB-4en-PINACA].
Wang KD; Yuan XL; Zhang YR; Hu JJ; Cao FQ; Chen YS
Fa Yi Xue Za Zhi; 2021 Aug; 37(4):505-510. PubMed ID: 34726003
[TBL] [Abstract][Full Text] [Related]
20. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
